ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery

ClinicalTrials.gov ID: NCT04561375

Public ClinicalTrials.gov record NCT04561375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery From Ambulatory Surgery

Study identification

NCT ID
NCT04561375
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
The Cleveland Clinic
Other
Enrollment
61 participants

Conditions and interventions

Interventions

  • Fentanyl Drug
  • Sufentanil Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 10, 2020
Primary completion
Jun 30, 2022
Completion
Jun 30, 2022
Last update posted
Dec 12, 2023

2020 – 2022

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Cleveland Clinic Fairview Hospital Cleveland Ohio 44111

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04561375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2023 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04561375 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →